Hippocampal Hyperactivation

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hippocampal Hyperactivation trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT07477431

Levetiracetam for Persons at Risk for Alzheimer's Disease

The goal of this clinical trial is to investigate whether very small doses of a drug called levetiracetam (LEV) may reduce abnormal brain signaling in individua…

Canada40 participantsStarted 2025-10-23

Treatment: Levetiracetam (LEV), Placebo

Hippocampal Hyperactivation

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Levetiracetam for Persons at Risk for Alzheimer's Disease

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Levetiracetam for Persons at Risk for Alzheimer's Disease

All recent trials (1 shown)